Figure 1 (Actemra 01)
This text is displaying the percentage of ACR20 responders which is not enough to generate a useful description.*
Actemra Injection, Solution, Concentrate
Product Images NDC 50242-137
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Actemra (NDC 50242-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Actemra 01a
Principal Display Panel (4 mL Vial Box)
This is a warning related to pre-filled syringe parts, particularly trigger fingers that should not be touched as this may release the needle-shield early. It also provides instructions for after use which involves extending and locking the needle-shield.*
Principal Display Panel (10 mL Vial Box)
The text listed here appears to be a collection of medical-related items that are commonly used in a medical setting. The items listed include a sharps container, which is used to dispose of medical sharps safely; an alcohol pad, which is commonly used to disinfect skin before injections; an ACTEMRA prefilled syringe, which is likely a type of medication; and a sterile cotton ball, which is often used to clean wounds or injections sites. *
Principal Display Panel (20 mL Vial Box)
Principal Display Panel (0.9 mL Syringe Box)
Actemra 06
Actemra 07
Actemra 08
Actemra 09
Actemra 10
Actemra 11
Actemra 12
Actemra 13
Actemra 14
The text contains a list of medical supplies including a Sharps container, alcohol pad, sterile cotton ball, and an Actemra ACTPen autoinjector, represented by Figure B.*
Actemra 15
Actemra 16
Actemra 17
Actemra 18
Actemra 19
Actemra 20
Actemra 21
Actemra 22
Actemra 23
Actemra 24
Actemra 25
Actemra 26
This text is the label for the Actemra medication, which is an injection used for intravenous infusion after dilution. It comes in a single-dose vial, without any preservatives. The medication guide is enclosed and should be provided to each patient. The NDC number is 50242-135-01 and the manufacturer is Genentech.*
Actemra 27
The text describes a medication called Actemra, which contains the active ingredient tocilizumab. It is administered as an intravenous infusion after dilution and is available in a single-dose vial containing 200mg of the drug in 10mL of solution. The medication guide enclosed in the package is required to be given to each patient receiving the drug. The medication does not contain any preservatives. There is also a manufacturer mentioned - Genentech.*
Actemra 28
The text describes a medication called Actemra, which is an injection containing tocilizumab. The vial contains 400mg/20 and is only for intravenous infusion. It is noted that the medication should be diluted before administration, and that the vial is a single dose, with any unused medication being discarded. The provider is reminded that each patient must receive an enclosed medication guide, and the medication does not contain any preservatives. The manufacturer is indicated as Genentech.*
Actemra 29
This is a medication package for Actemra (tocilizumab) injection. It contains a prefilled syringe with 162mg/0.9 mL of the medication for subcutaneous injection only. The pharmacist should remind the patient to read the enclosed medication guide. The unused portion of the syringe should be disposed of properly. The medication should be kept refrigerated. The package is sterile.*
Actemra 30
This is a medication package containing Actemra®/’® ACTPen® for subcutaneous injection only. It includes a sterile syringe with a dosage of 162mg/0.9mL and a purple indicator to notify when injection is complete. Patients must receive the enclosed Medication Guide before taking this medication. The unopened package must be refrigerated immediately, and any unused or discarded portion should be disposed of in a single-dose autoinjector.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
